Neuropathic Pain Market Report Overview:
The neuropathic pain market reached a value of US$ 5.5 Billion in 2023 and expected to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.7% during 2024-2034.
The report offers a comprehensive analysis of the neuropathic pain market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the neuropathic pain market.
Request a Free PDF Sample for More Detailed Market Insights:
https://www.imarcgroup.com/neuropathic-pain-market/requestsample
The market for neuropathic pain is expanding, primarily fueled by a surge in chronic diseases causing nerve damage and escalating instances of peripheral nerve injuries. The rising use of treatments like anticonvulsants and tricyclic antidepressants, known for their ability to stabilize nerve cells and reduce specific neurotransmitter release, is significantly contributing to market growth. Further, the increasing adoption of nerve blocks, especially epidural injections that interrupt pain signals to the brain, is fostering a favorable market scenario. The growing popularity of transcutaneous electrical nerve stimulation (TENS), a non-invasive therapy that uses low-voltage currents to activate nerve fibers for pain relief, is also augmenting market expansion.
Moreover, the application of psychological treatments like cognitive-behavioral therapy and mindfulness-based methods to address the emotional and psychological aspects of neuropathic pain is propelling growth. An upward trend in the use of nerve stimulation techniques, including spinal cord stimulation, peripheral nerve stimulation, and deep brain stimulation, aimed at relieving symptoms by targeting specific nerves or brain areas related to pain, is anticipated to push the neuropathic pain market forward in the future.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country:
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the neuropathic pain market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the neuropathic pain market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current neuropathic pain marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Competitive Landscape With Key Players:
The competitive landscape of the neuropathic pain markethas been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=6910flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
